课题基金 / 基金详情

项目摘要

项目成果

Rinad Sary Beidas的其他基金

相似基金

相关文献

中文摘要
翻译
这个P50应用程序代表了行为经济学和 追求改善癌症护理服务的实施科学。大学的行政核心 宾夕法尼亚州癌症控制实施科学中心(宾夕法尼亚州ISC3)将提供 操作和科学监督。它将由宾夕法尼亚大学ISC3的三名首席调查员Beidas博士领导, Bekelman和Schnoll与内部执行委员会和外部咨询委员会合作。 行政核心的具体目标如下:1)提供必要的管理和整合 宾夕法尼亚大学ISC3活动(业务结构),其中将包括行政支助、会议协调、 确保有效利用内部执行委员会和外部咨询委员会; 作为宾夕法尼亚大学癌症实施科学(IS)研究的中心(IS外联),这将涉及 协调教育活动,利用宾夕法尼亚大学的基本伙伴关系,开展活动以确保 沟通,与通过该机制资助的其他中心接触,并协调年度务虚会; (3)协调中心研究成果的沟通和传播,建设研究能力 以及与其他月球射击奖获得者的合作,并支持国家实施科学和癌症 研究社区(网络单位);以及(4)支持、监测和评估中心进展(评价单位), 这将确保完成拟议的研究,确定中心的更广泛影响,并帮助 将拟议研究的结果转化为后续资助的研究项目。最重要的优先事项 因为行政核心是确保宾夕法尼亚州立大学ISC3的影响是强大的,并大于 它的各个部分。它将通过协调服务和最大限度地发挥研究计划之间的协同作用来做到这一点, 实施实验室,以及其他中心活动。行政核心将与研究对接 定期计划(项目绩效指标和方法单位),以确保每个实体都达到目标和目的,以及 根据需要解决问题。拟议的宾夕法尼亚州立大学ISC3将汇集来自 多学科,这将创造一个肥沃的环境,长期目标是改善癌症护理 并与主要利益攸关方合作,对公共卫生产生持续影响。归根结底, 宾夕法尼亚大学ISC3管理核心将创造一种特殊的科学文化,并通过以下方式确保中心的成功 刺激和指导新的概念和方法进步,支持信息系统和 宾夕法尼亚大学和全国的癌症研究,以及推进肿瘤学护理中的实施科学。 PHS 398/2590(06/09版)页面续格式页面
英文摘要
This P50 application represents a novel interdisciplinary center at the intersection of behavioral economics and implementation science in pursuit of improving cancer care delivery. The Administrative Core for the University of Pennsylvania Implementation Science Center in Cancer Control (Penn ISC3) will provide overarching operational and scientific oversight. It will be led by the three Penn ISC3 Principal Investigators, Drs. Beidas, Bekelman, and Schnoll, in collaboration with an Internal Executive Committee and an External Advisory Board. The Specific Aims of the Administrative Core are as follows: 1) To provide essential management and integration of Penn ISC3 activities (operational structure),which will include administrative support, meeting coordination, and ensuring the effective use of the Internal Executive Committee and an External Advisory Board; (2) To serve as the hub for implementation science (IS) research in cancer at Penn (IS outreach), which will involve coordination of educational activities, drawing upon essential partnerships at Penn, engage in activities to ensure communication, engaging with other centers funded through this mechanism, and coordinating an annual retreat; (3) To coordinate communication and dissemination of the Center’s research findings, build research capacity and collaboration with other Moonshot awardees, and support a national implementation science and cancer research community (network unit); and (4) To support, monitor, and evaluate Center progress (evaluation unit), which will ensure completion of proposed studies, determine the broader impact of the Center, and help to translate the results of the proposed studies into subsequent funded research projects. The overarching priority for the Administrative Core is to ensure that the impact of the Penn ISC3 is robust and greater than the sum of its parts. It will do so by coordinating services and maximizing synergies among the Research Program, Implementation Laboratory, and other center activities. The Administrative Core will interface with the Research Program (Project PIs and Methods Unit) regularly to ensure that each entity is meeting goals and objectives, and problem solve as necessary. The proposed Penn ISC3 will bring together junior and senior investigators from multiple disciplines, which will create a fertile environment with the long-term goal of improving cancer care delivery and exerting a sustained impact on public health in partnership with key stakeholders. Ultimately, the Penn ISC3 Administrative Core will create a culture of exceptional science and ensure the Center’s success by stimulating and guiding new conceptual and methodological advancements, supporting the growth of IS and cancer research at Penn and nationally, and advancing the science of implementation within oncology care. PHS 398/2590 (Rev. 06/09) Page Continuation Format Page
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Leveraging behavioral economics to equitably implement cascade screening in individuals with familial hypercholesterolemia in partnership with the FH Foundation
Leveraging behavioral economics to equitably implement cascade screening in individuals with familial hypercholesterolemia in partnership with the FH Foundation
  • 批准号:
    10367999
  • 项目类别:
  • 资助金额:
    $39.22万
  • 财政年份:
    2022
  • 负责人:
    Rinad Sary Beidas
  • 依托单位:
Eliminating Monitor Overuse (EMO) Hybrid Effectiveness-Deimplementation Trial
  • 批准号:
    10689754
  • 项目类别:
  • 资助金额:
    $114.08万
  • 财政年份:
    2021
  • 负责人:
    Rinad Sary Beidas
  • 依托单位:
Eliminating Monitor Overuse (EMO) Hybrid Effectiveness-Deimplementation Trial
  • 批准号:
    10315079
  • 项目类别:
  • 资助金额:
    $72.32万
  • 财政年份:
    2021
  • 负责人:
    Rinad Sary Beidas
  • 依托单位:
海外基金